KALA vs STZ · $54.3M cap vs P/E 14, rev $9.14B
Kala Pharmaceuticals Inc (KALA) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Kala Pharmaceuticals Inc (KALA) is a biotechnology company listed on NASDAQ.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported KALA revenue for 2025-12-31 was $0. Net income was -$27.0M. KALA currently screens at market cap $54.3M.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
KALA currently screens at market cap $54.3M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the KALA and STZ stock pages for the full models.
Not investment advice.